Jul 28, 2026
8:1
For every share held, investors received 8. The price per share adjusted from $596.48 to $74.56.
The split itself did not change the total investment value.
Vertex Pharmaceuticals Incorporated (B3:VRTX34) operates in the Pharmaceuticals: major industry.
Vertex Pharmaceuticals Incorporated company overviewVertex Pharmaceuticals Incorporated's most recent stock split was on July 28, 2026. It was a 8-for-1 forward split, so shareholders received 8 shares for every share they held.
Vertex Pharmaceuticals Incorporated has split its stock once. This history records one forward split, on July 28, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Vertex Pharmaceuticals Incorporated's 8-for-1 split on July 28, 2026, every share became 8 shares.
Vertex Pharmaceuticals Incorporated has not announced a new split in our records. Its most recent split was on July 28, 2026, less than a year ago. Companies announce splits in advance, and any new B3:VRTX34 split will appear on this page.